Quantification of Female Chimeric Cells in the Tonsils of Male Children and Their Determinants.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 08 2023
Historique:
received: 19 07 2023
revised: 03 08 2023
accepted: 14 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

The factors influencing mother-to-child cell trafficking and persistence over children's lives have yet to be established. The quantification of maternal microchimerism was previously reported through HLA-based approaches, which introduced bias regarding the tolerogenic environment. We aimed to identify cells of maternal origin irrespective of the HLA repertoire and to ascertain the determinants of microchimeric cells. This case-control study enrolled 40 male infants attending pediatric surgery from January 2022 to October 2022. Female cells were quantified in infants' tonsil tissue by using cytogenetic fluorescent in situ hybridization (FISH) coupled with optimized automated microscopy. Out of the 40 infants, half (47.4%) had been breastfed for more than one month, a quarter for less a month, and 10 children (26.3%) were never breastfed. XX cells were observed in male tonsils in two-thirds of participants at a median density of 5 cells per 100,000 cells. In univariate analyses, child age was negatively associated with a high female cell density. In exploratory multivariate analyses, previous breastfeeding is a likely determinant of the persistence of these cells in the host, as well as the rank among siblings. Part of the benefit of breastmilk for child health may therefore be driven by breastfeeding-related microchimerism.

Identifiants

pubmed: 37626925
pii: cells12162116
doi: 10.3390/cells12162116
pmc: PMC10453410
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pediatrics. 2010 Jul;126(1):e18-25
pubmed: 20566605
Dev Growth Differ. 2023 Jan;65(1):75-81
pubmed: 36519824
Nat Rev Immunol. 2017 Nov;17(11):729-1
pubmed: 28972205
PLoS One. 2010 Dec 28;5(12):e14421
pubmed: 21203434
Cell. 2015 Jul 30;162(3):505-15
pubmed: 26213383
Lab Invest. 2006 Nov;86(11):1185-92
pubmed: 16969370
Curr Opin Infect Dis. 2015 Jun;28(3):199-206
pubmed: 25887614
Clin Chem. 2021 Jan 30;67(2):351-362
pubmed: 33417673
Annu Rev Pathol. 2017 Jan 24;12:419-447
pubmed: 28135562
Biol Open. 2022 Nov 1;11(11):
pubmed: 36349799
Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Oct;129(5):264-71
pubmed: 23078979
J Immunol. 2016 Sep 15;197(6):2290-6
pubmed: 27496970
Pediatr Allergy Immunol. 2018 Mar;29(2):133-143
pubmed: 29197124
Gut Microbes. 2023 Jan-Dec;15(1):2190305
pubmed: 37055920
PLoS One. 2013 Sep 11;8(9):e74534
pubmed: 24040274
Lancet Glob Health. 2016 Apr;4(4):e266-75
pubmed: 27013313
Front Immunol. 2022 Jul 01;13:837281
pubmed: 35844513
Bioessays. 2015 Oct;37(10):1106-18
pubmed: 26316378
Sci Rep. 2018 Sep 24;8(1):14289
pubmed: 30250150
Adv Exp Med Biol. 2012;743:121-37
pubmed: 22454346
Blood. 2010 Oct 14;116(15):2706-12
pubmed: 20628146
Chimerism. 2015 Apr 3;6(1-2):8-20
pubmed: 26517600
J Clin Invest. 2022 Jul 1;132(13):
pubmed: 35550376
Front Immunol. 2021 Feb 12;12:604080
pubmed: 33643310
Chimerism. 2010 Jul-Sep;1(1):11-4
pubmed: 21327147
Adv Immunol. 2012;115:73-111
pubmed: 22608256
Nat Rev Immunol. 2017 Aug;17(8):483-494
pubmed: 28480895
PLoS One. 2016 Jun 10;11(6):e0156762
pubmed: 27285085
Chimerism. 2015 Oct 2;6(4):65-71
pubmed: 27623703
EBioMedicine. 2021 Dec;74:103721
pubmed: 34844192
Lancet. 2016 Jan 30;387(10017):475-90
pubmed: 26869575
BMC Med. 2021 Apr 13;19(1):90
pubmed: 33845843
Chimerism. 2011 Apr;2(2):50-4
pubmed: 21912719
Hum Genet. 2001 Mar;108(3):199-204
pubmed: 11354630
iScience. 2021 Dec 29;25(1):103664
pubmed: 35072002
Pediatr Res. 2010 Sep;68(3):199-204
pubmed: 20531252
Am J Phys Anthropol. 2021 Feb;174(2):213-223
pubmed: 33300155

Auteurs

Boris Dmitrenko (B)

Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, 34394 Montpellier, France.

Vincent Gatinois (V)

Unit of Chromosomal Genetics and Research Plateform Chromostem, Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier CHRU, 34090 Montpellier, France.

Morgana D'Ottavi (M)

Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, 34394 Montpellier, France.

Ahmed El Mouatani (A)

Unit of Chromosomal Genetics and Research Plateform Chromostem, Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier CHRU, 34090 Montpellier, France.

Pauline Bouret (P)

Unit of Chromosomal Genetics and Research Plateform Chromostem, Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier CHRU, 34090 Montpellier, France.

Ségolène Debiesse (S)

Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, 34394 Montpellier, France.

Michel Mondain (M)

Department of ENT and Head and Neck Surgery, Gui de Chauliac Hospital, University of Montpellier, 34295 Montpellier, France.

Mohamed Akkari (M)

Department of ENT and Head and Neck Surgery, Gui de Chauliac Hospital, University of Montpellier, 34295 Montpellier, France.

Maxime Dallemagne (M)

Department of ENT and Head and Neck Surgery, Gui de Chauliac Hospital, University of Montpellier, 34295 Montpellier, France.

Franck Pellestor (F)

Unit of Chromosomal Genetics and Research Plateform Chromostem, Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier CHRU, 34090 Montpellier, France.

Philippe Vande Perre (PV)

Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, 34394 Montpellier, France.

Jean-Pierre Molès (JP)

Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, 34394 Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH